loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of Health Canada Patents covering Mepolizumab.

    Client Email Product
    Menu

    Mepolizumab

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GlaxoSmithKline Inc. (1)

    filter

    01 2208503 (1)

    filter

    01 MEPOLIZUMAB (1)

    filter

    01 POWDER FOR SOLUTION (1)

    filter

    01 2015-12-22 (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    GlaxoSmithKline Inc.

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mepolizumab

    PDF Supplier PDF
    URL Supplier Web Content
    2208503
    100 mg / mL
    POWDER FOR SOLUTION
    Human
    2015-12-22
    2009-01-12
    1995-12-22
    NUCALA
    SUBCUTANEOUS
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY